Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Petric

Showing results (61-70 of 95) with videos related to

Pageof 10
Sort By:
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|December 12, 2022
Serial cross-sectional estimation of vaccine-and infection-induced SARS-CoV-2 seroprevalence in British Columbia, CanadaDanuta M Skowronski, Samantha E Kaweski, Michael A Irvine, et al.
Journal of Medical Virology|September 28, 2010
Comparison of the incidence of influenza in relation to climate factors during 2000-2007 in five countriesJulian W Tang, Florence Y L Lai, P Nymadawa, et al.
Emerging Infectious Diseases|January 25, 2005
Human illness from avian influenza H7N3, British ColumbiaS Aleina Tweed, Danuta M Skowronski, Samara T David, et al.
The Journal of Infectious Diseases|August 9, 2012
Cross-reactive and vaccine-induced antibody to an emerging swine-origin variant of influenza A virus subtype H3N2 (H3N2v)Danuta M Skowronski, Naveed Z Janjua, Gaston De Serres, et al.
Open Forum Infectious Diseases|September 29, 2018
Should Sex Be Considered an Effect Modifier in the Evaluation of Influenza Vaccine Effectiveness?Catharine Chambers, Danuta M Skowronski, Caren Rose, et al.
The Journal of General Virology|August 30, 2008
Severe acute respiratory syndrome vaccine efficacy in ferrets: whole killed virus and adenovirus-vectored vaccinesRaymond H See, Martin Petric, David J Lawrence, et al.
Access Microbiology|December 10, 2021
Performance comparison of micro-neutralization assays based on surrogate SARS-CoV-2 and WT SARS-CoV-2 in assessing virus-neutralizing capacity of anti-SARS-CoV-2 antibodiesInna Sekirov, Martin Petric, Erin Carruthers, et al.
BMJ (Clinical Research Ed.)|February 5, 2011
Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009Danuta M Skowronski, Naveed Z Janjua, Gaston De Serres, et al.
International Journal of Cancer|November 12, 2009
GBV-C/hepatitis G virus infection and non-Hodgkin lymphoma: a case control studyMel Krajden, Amanda Yu, Heather Braybrook, et al.
Microbiology Spectrum|September 19, 2022
Correlation of SARS-CoV-2 Viral Neutralizing Antibody Titers with Anti-Spike Antibodies and ACE-2 Inhibition among Vaccinated IndividualsBrian Grunau, Martin Prusinkiewicz, Michael Asamoah-Boaheng, et al.
Pageof 10

Showing results (61-70 of 95) with videos related to

Sort By:
Pageof 10
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|December 12, 2022
Serial cross-sectional estimation of vaccine-and infection-induced SARS-CoV-2 seroprevalence in British Columbia, CanadaDanuta M Skowronski, Samantha E Kaweski, Michael A Irvine, et al.
Journal of Medical Virology|September 28, 2010
Comparison of the incidence of influenza in relation to climate factors during 2000-2007 in five countriesJulian W Tang, Florence Y L Lai, P Nymadawa, et al.
Emerging Infectious Diseases|January 25, 2005
Human illness from avian influenza H7N3, British ColumbiaS Aleina Tweed, Danuta M Skowronski, Samara T David, et al.
The Journal of Infectious Diseases|August 9, 2012
Cross-reactive and vaccine-induced antibody to an emerging swine-origin variant of influenza A virus subtype H3N2 (H3N2v)Danuta M Skowronski, Naveed Z Janjua, Gaston De Serres, et al.
Open Forum Infectious Diseases|September 29, 2018
Should Sex Be Considered an Effect Modifier in the Evaluation of Influenza Vaccine Effectiveness?Catharine Chambers, Danuta M Skowronski, Caren Rose, et al.
The Journal of General Virology|August 30, 2008
Severe acute respiratory syndrome vaccine efficacy in ferrets: whole killed virus and adenovirus-vectored vaccinesRaymond H See, Martin Petric, David J Lawrence, et al.
Access Microbiology|December 10, 2021
Performance comparison of micro-neutralization assays based on surrogate SARS-CoV-2 and WT SARS-CoV-2 in assessing virus-neutralizing capacity of anti-SARS-CoV-2 antibodiesInna Sekirov, Martin Petric, Erin Carruthers, et al.
BMJ (Clinical Research Ed.)|February 5, 2011
Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009Danuta M Skowronski, Naveed Z Janjua, Gaston De Serres, et al.
International Journal of Cancer|November 12, 2009
GBV-C/hepatitis G virus infection and non-Hodgkin lymphoma: a case control studyMel Krajden, Amanda Yu, Heather Braybrook, et al.
Microbiology Spectrum|September 19, 2022
Correlation of SARS-CoV-2 Viral Neutralizing Antibody Titers with Anti-Spike Antibodies and ACE-2 Inhibition among Vaccinated IndividualsBrian Grunau, Martin Prusinkiewicz, Michael Asamoah-Boaheng, et al.
Pageof 10